Results
Biocon's Q4 Profit Drops 56.8% with Full-Year Profit Also Down Significantly

This impact news covers Biocon's financial performance for the fourth quarter of the fiscal year. The company has reported a significant 56.8% drop in net profit for the January-March period, totalling ₹198.6 crore. This decline was impacted by an exceptional expense of ₹80.4 crore. Looking at the full financial year, Biocon's profit also saw a considerable decrease, standing at ₹368.8 crore compared to the previous year. This development in the Results category offers insights into the company's recent financial trajectory within the Indian pharmaceutical and biotechnology sector. Investors and market watchers will be keen to understand the factors contributing to this negative trajectory and its implications for the Indian stock market and the broader healthcare industry.
More in Results

Results
Bharti Airtel Q1 FY27 Earnings Explained: ARPU, Growth and Key Takeaways

Results
Bajaj Finserv Q1 Profit Rises 12% as Strong Results Lift Shares 5%
- Bajaj Finserv posted a 12% YoY rise in Q1 net profit to ₹3,132 crore, beating estimates.
- The stock gained nearly 5% after investors welcomed strong earnings and business momentum.
- Insurance and lending businesses continue steady earnings growth during the quarter